Ron Wyden stock trades
Ron Wyden · OR
All members →3 Senate reports since 2025
Ron Wyden
Democrat · U.S. Senator from Oregon
U.S. Senator since 1996
Trades
6
3 reports · 0 bonds/funds/other
Buys
1
~$75.0K
Sells
4
~$99.0K
Filing delay
30d
1 report past 45 days
Mostly
Spouse 100%
whose account traded
Top ticker
BERY
1 trades · ~$175.0K
How their buys did
- Average since buying
- +68.8%
- Versus SPY, same days
- +40.4%
- Buys that beat SPY
- 100%
- Copying after filing
- +15.7%
- After selling, the stock did vs SPY
- +4.0% (on average it kept up with or beat SPY after they sold)
1 buys with a price, measured from the trade date to the latest close, dividends included. Not weighted by size.
Bought and sold by month (est.)
What they trade most
6 trades
| Traded | Ticker | Asset | Owner | Type | Amount | Filed | Since | vs SPY | Report |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 25 | PFE | Pfizer, Inc. Common Stock | Spouse | Sell | $1,001 - $15,000 | Jul 2, 25 (29d) | +37.9% | +7.7% | Report |
| Apr 30, 25 | BERY | BERY - Berry Global Group, Inc. (Exchanged); Amcor plc Ordinary Shares (Received) | Spouse | Exchange | $100,001 - $250,000 | Aug 8, 26 (465d) | — | — | Report |
| Feb 10, 25 | LLY | Eli Lilly and Company Common Stock | Spouse | Sell | $50,001 - $100,000 | Feb 21, 25 (11d) | +46.5% | +17.8% | Report |
| Feb 6, 25 | IRBT | iRobot Corporation - Common Stock | Spouse | Sell | $1,001 - $15,000 | Feb 21, 25 (15d) | — | — | Report |
| Feb 6, 25 | SOLV | Solventum Corporation | Spouse | Sell | $1,001 - $15,000 | Feb 21, 25 (15d) | +14.7% | −13.6% | Report |
| Jan 22, 25 | LLY | Eli Lilly and Company Common Stock | Spouse | Buy | $50,001 - $100,000 | Feb 21, 25 (30d) | +68.8% | +40.4% | Report |
From the senator's Periodic Transaction Reports on the Senate's financial disclosure site (efdsearch.senate.gov). Members report value ranges up to 45 days after a trade, so amounts are estimates (range midpoints). “Since” is the stock's change from the trade date to the latest close; hover it for the change since the report was filed. Not investment advice.